cabozantinib–nivolumab and ipilimumab combinations show potential for gu cancers | andrea apolo
Published 3 years ago • 174 plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
0:55
dr. apolo on the combination of cabozantinib plus nivolumab in urothelial carcinoma
-
2:09
dr. apolo on cabozantinib plus nivolumab and ipilimumab in urothelial carcinoma
-
0:57
exploring cabozantinib with nivolumab and ipilimumab in urothelial carcinoma
-
1:13
dr. apolo on the safety of nivolumab plus cabozantinib in urothelial carcinoma
-
0:56
dr. apolo on immunotherapy combinations with cabozantinib in genitourinary tumors
-
2:40
combining agents to improve response rates in genitourinary cancer
-
6:51
success for ipilimumab and nivolumab combo in advanced melanoma
-
3:49
cabozantinib benefit for metastatic papillary rcc demonstrated | sumanta pal
-
0:49
dr. apolo on side effects of cabozantinib plus immunotherapy agents in bladder cancer
-
2:10
ipilimumab combined with nivolumab for patients with melanoma
-
1:22
dr. sznol discusses the combination of ipilimumab and nivolumab in melanoma
-
1:25
dr. ott discusses ipilimumab and nivolumab in melanoma
-
5:39
nivolumab plus ipilimumab in advanced melanoma
-
0:55
dr. apolo on avelumab for metastatic urothelial carcinoma
-
0:46
the benefits of nivolumab and relatlimab in melanoma
-
1:15
immunotherapy drug more effective than another in treating melanoma
-
8:28
success for ipilimumab and nivolumab combo in advanced melanoma
-
2:11
ipilimumab and nivolumab for melanoma brain metastases